Vertex Diabetes Cell Therapy Trial On Hold – As First Patient Free From Insulin Injections

Company Defends Safety And Reveals Promising Efficacy Data

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.